Hologic Names Two Icahn-Backed Directors to Board

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

Dec. 9 (Bloomberg) -- Hologic, a maker of cervical cancer and breast biopsy tools, added two independent directors to its board under an agreement with billionaire investor Carl Icahn. The company also picked a new chief executive officer. Scarlet Fu reports on Bloomberg Television's "In The Loop." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change